Sonnet BioTherapeutics Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IFP ADVISORS, INC | 11/08/2022 | 2,000 | $13,000 | 0.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 11/15/2022 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/10/2022 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/10/2022 | 0 | $0 | -100.00% | 0.00% |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 10/24/2022 | 0 | $0 | -100.00% | 0.00% |
| CAMPION ASSET MANAGEMENT | 11/10/2022 | 0 | $0 | -100.00% | 0.00% |
| RATIO WEALTH GROUP | 03/27/2023 | 0 | $0 | -100.00% | 0.00% |
Sonnet BioTherapeutics Holdings, Inc.institutional Ownership - FAQ's
Who are the largest shareholders of SONN shares?
During the previous two years, 1 institutional investors and hedge funds held shares of Sonnet BioTherapeutics Holdings, Inc.. The most heavily invested institutionals were:
Carroll Financial Associates, Inc.: 10
What percentage of Sonnet BioTherapeutics Holdings, Inc. stock is owned by
institutional investors?
0.05% of Sonnet BioTherapeutics Holdings, Inc. stock is owned by institutional investors.
How much institutional buying is happening at SONN ?
Institutional investors have bought a total of 10 shares in the last 24 months. This purchase volume represents approximately $16 in transactions.